Evaluation of the impact on disease severity of treatment-related educational advice delivered by general practice-based clinical pharmacists to the parents/carers of children with atopic eczema: a randomised study

Rotherham, Doncaster, and South Humber NHS Foundation Trust (RDaSH)0 个研究点目标入组 32 人开始时间: 2021年2月1日最近更新: 2024年4月22日

适应症

试验速览

2024 Results article see attached file ISRCTN17846245 Results article.pdf (added 12/04/2024)

•1. Parents of children aged 6 months - 6 years with a diagnosis of atopic eczema made by a GP or an appropriately qualified health care professional recorded in their medical notes
•2. Children currently prescribed (prescriptions issued for the previous three months) one or more of the following treatments:
•2.1. Any emollient products e.g. creams, ointments, bathing products, etc.
•2.2. Topical steroids
•2.3. Topical immunomodulators

•1. Parents (or carers) without adequate spoken and written English, as determined by the pharmacist, will be excluded as the study does not have sufficient funding to allow for the provision of an interpreter or for the education information to be translated into other languages
•2. Children under the care of a dermatologist or other dermatology specialist
•3. Children attending any specialist nurse-led eczema clinic
•Children in the above categories are excluded because it is assumed that they will have received sufficient educational support and are therefore unlikely to benefit from additional advice

发起方

Rotherham, Doncaster, and South Humber NHS Foundation Trust (RDaSH)